Is Hyperleptinemia a Risk Factor for Hypertension?

被引:2
作者
Rafique, Nazish [1 ]
Afzal, Nasir [1 ]
机构
[1] Shifa Int Hosp, Dept Basic Hlth Sci, Shifa Coll Med, Islamabad, Pakistan
关键词
BMI; hyperleptinemia; hypertension; leptin; obesity; sympathetic activity;
D O I
10.4103/1658-631X.112930
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Major risk factors of hypertension (HTN) including obesity, insulin resistance, renal pathology, increased sympathetic nerve activity (SNA) and vascular inflammation are associated with hyperleptinemia. Therefore hyperleptinemia may act as a mediator of blood pressure, linking body fat mass with changes in insulin action, sympathetic neuronal outflow and renal pathology. Objective: The objective of our study was to explore the relationship between hyperleptinemia and HTN in Pakistani population. Materials and Methods: It was a case control study of 6 months duration, carried out at Shifa College of Medicine and Shifa International Hospital, Islamabad. One hundred and four male subjects, 52 with HTN and 52 without HTN were included in this study. Leptin levels were measured by enzyme-linked immunosorbent assay (ELISA) technique. The relationship of leptin (LEP), body mass index (BMI), fasting blood sugar (FBS) and cholesterol levels with blood pressure were assessed. Results: Patients with HTN versus patients without HTN had a higher body mass index (28.0 +/- 0.12 to 24.11 +/- 0.27 kg/m(2)), FBS (169.20 +/- 7.34 to 127.50 +/- 2.30 mg/dl), total cholesterol (160 +/- 3.72 to 158 +/- 2.71 mg/dl) and LEP (53.40 +/- 5.32 to 21.65 +/- 3.50 ng/ml) levels. In univariate analysis, obesity, hyperglycemia and hyperleptinemia (with P values of 0.000, 0.001, 0.000, respectively), whereas in multivariate analysis, hyperglycemia and hyperleptinemia (with P values of 0.006 and 0.001, respectively) were risk factors for HTN. Our study also showed that hyperleptinemia is an independent risk factor for HTN. Conclusions: We observed a strong positive relationship between hyperleptinemia and hypertension, thereby indicating that increased leptin levels could be considered as a risk factor for HTN and cardiovascular disease. Further studies are needed to probe the underlying pathophysiological mechanisms responsible for hyperleptinemia in HTN.
引用
收藏
页码:40 / 45
页数:6
相关论文
共 35 条
[1]  
Alexandre DS, 2009, CURR HYPERTENS REP, V11, P206
[2]   Leptin is not associated independently with hypertension in Japanese-Brazilian women [J].
Almeida-Pititto, B ;
Gimeno, SGA ;
Freire, RD ;
Ribeiro, FF ;
Ferreira, SRG .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2006, 39 (01) :99-105
[3]   Hyperleptinemia as a risk factor in obesity-related hypertension [J].
Alvarez-Aguilar, C ;
Mondragón-Jiménez, LI ;
Ramírez-Enríquez, J ;
Gómez-García, A ;
Paniagua-Sierra, R ;
Amato, D .
MEDICINA CLINICA, 2004, 123 (20) :766-769
[4]  
Beltowski J, 2006, J HYPERTENS, V24, P789
[5]   The concept of selective leptin resistance - Evidence from agouti yellow obese mice [J].
Correia, MLG ;
Haynes, WG ;
Rahmouni, K ;
Morgan, DA ;
Sivitz, WI ;
Mark, AL .
DIABETES, 2002, 51 (02) :439-442
[6]   Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats [J].
Dunbar, JC ;
Hu, YG ;
Lu, HQ .
DIABETES, 1997, 46 (12) :2040-2043
[7]   Gender-specific correlates of leptin with hypertension-related phenotypes in African Americans [J].
El-Gharbawy, AH ;
Kotchen, JM ;
Grim, CE ;
Kaldunski, M ;
Hoffmann, RG ;
Pausova, Z ;
Hamet, P ;
Kotchen, TA .
AMERICAN JOURNAL OF HYPERTENSION, 2002, 15 (11) :989-993
[8]   High-circulating leptin levels are associated with greater risk of hypertension in men independently of body mass and insulin resistance: Results of an eight-year follow-up study [J].
Galletti, F. ;
D'Elia, L. ;
Barba, G. ;
Siani, A. ;
Cappuccio, F. P. ;
Farinaro, E. ;
Iacone, R. ;
Russo, O. ;
De Palma, D. ;
Ippolito, R. ;
Strazzullo, P. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10) :3922-3926
[9]   Interaction between leptin and sympathetic nervous system in hypertension [J].
Haynes W.G. .
Current Hypertension Reports, 2000, 2 (3) :311-318
[10]   Recombinant leptin for weight loss in obese and lean adults - A randomized, controlled, dose-escalation trial [J].
Heymsfield, SB ;
Greenberg, AS ;
Fujioka, K ;
Dixon, RM ;
Kushner, R ;
Hunt, T ;
Lubina, JA ;
Patane, J ;
Self, B ;
Hunt, P ;
McCamish, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (16) :1568-1575